Weave Bio Secures $20M Series A Funding to Enhance Its AI-Native Regulatory Platform
SAN FRANCISCO–(BUSINESS WIRE)–Weave Bio, a pioneer in AI-native regulatory automation management solutions, today announced its $20 million Series A funding, bringing the company’s total capital raised to $36 million. The round was led by USVP,…